Quince Therapeutics, Inc. Share Price

Quince Therapeutics, Inc. Share Price

NASDAQ: QNCX
$0.00
+0.00 (0.00%)
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Quince Therapeutics, Inc. Stock Performance

Open
N/A
Prev. Close
N/A
Circuit Range
N/A
Day Range
N/A
Year Range
N/A
Volume
N/A
Average Traded
N/A

Quince Therapeutics, Inc. Share Price Chart

$0.00$0.00
L
Show Current Price
H

Quince Therapeutics, Inc. Stock Fundamentals & Key Indicators

Market Cap
N/A
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-93.99
Revenue (TTM)
$0.00
Return On Equity (TTM)
-88.12%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-461.68%

Quince Therapeutics, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$13.44-$39.46$32.79-$75.49
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-193.60%183.10%-330.22%

Quince Therapeutics, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$0.00$0.00
Net Profit-$51.66-$31.39-$56.83-$83.98
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A39.24%-81.04%-47.77%

About Quince Therapeutics, Inc.

Quince Therapeutics Inc is a late-stage biotechnology company dedicated to unlocking the power of a patient's own biology for the treatment of rare diseases. Its proprietary AIDE technology is an inventive drug/device combination platform that uses an automated process to encapsulate a drug into a patient's own red blood cells. Its Phase 3 asset, eDSP, leverages the AIDE technology to encapsulate DSP into a patient's own red blood cells, and is targeted to treat a rare pediatric neurodegenerative disease, A-T.

Quince Therapeutics, Inc. Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %

QNCX Share Price FAQs